Scarica l'app Stockscreener
1.63
6.29%
0.12
Precedente Chiudi:
$1.51
Aprire:
$1.53
Volume 24 ore:
135.73K
Relative Volume:
0.44
Capitalizzazione di mercato:
$50.54M
Reddito:
$1.05M
Utile/perdita netta:
$-48.82M
Rapporto P/E:
-0.8907
EPS:
-1.83
Flusso di cassa netto:
$-47.49M
1 W Prestazione:
+0.31%
1M Prestazione:
+5.59%
6M Prestazione:
+45.91%
1 anno Prestazione:
-19.75%
Intervallo 1D:
$1.49
$1.64
Intervallo di 1 settimana:
$1.39
$1.64
Portata 52W:
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Nome
Actinium Pharmaceuticals Inc
Settore
Industria
Telefono
646-767-3870
Indirizzo
275 Madison Avenue, 7th Floor, New York, NY
Confronta ATNM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.62 | 45.86M | 1.05M | -48.82M | -47.49M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.60 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.07 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.49 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.68 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
303.40 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-07 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Iniziato | B. Riley Securities | Buy |
| 2020-11-05 | Iniziato | Alliance Global Partners | Buy |
| 2017-12-06 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Ripresa | ROTH Capital | Buy |
| 2017-09-14 | Iniziato | Maxim Group | Buy |
| 2016-08-25 | Iniziato | ROTH Capital | Buy |
| 2016-02-29 | Iniziato | H.C. Wainwright | Buy |
| 2015-10-15 | Iniziato | FBR Capital | Outperform |
| 2014-10-01 | Iniziato | MLV & Co | Buy |
| 2014-07-22 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie
Actinium Pharmaceuticals Inc. Price Targets Raised After ReboundWeekly Investment Recap & Community Consensus Trade Signals - beatles.ru
How to track smart money flows in Actinium Pharmaceuticals Inc.July 2025 Weekly Recap & Daily Profit Focused Stock Screening - Newser
Will Actinium Pharmaceuticals Inc. rebound enough to break evenJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser
How to manage a losing position in Actinium Pharmaceuticals Inc.Global Markets & High Win Rate Trade Alerts - Newser
Analyzing drawdowns of Actinium Pharmaceuticals Inc. with statistical toolsPredictive Analytics for Equity Growth Potential - Newser
Can Actinium Pharmaceuticals Inc. hit a new high this monthFree Market Surge Signal for Swing Traders - Newser
Visualizing Actinium Pharmaceuticals Inc. stock with heatmapsFree Stock Selection With High Accuracy - Newser
Can technical indicators confirm Actinium Pharmaceuticals Inc.’s reversalFree Short Term Trading Opportunity Watch - Newser
Has Actinium Pharmaceuticals Inc. formed a bullish divergenceNeural Model for Stock Price Movement - Newser
Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionFree Oversold Recovery Opportunity Stocks - Newser
What’s the recovery path for long term holders of Actinium Pharmaceuticals Inc.Free AI Driven Buy Alert Trade Blueprint - Newser
Actinium Pharmaceuticals Inc. stock daily chart insightsFree Earnings Play Trade Plan With Alerts - Newser
Visual analytics tools that track Actinium Pharmaceuticals Inc. performanceAsset Safety Selection Using Quantitative Analysis - Newser
Actinium Pharmaceuticals Inc.’s volatility index tracking explainedWeekly Trend Screener with Momentum Picks - Newser
Analyzing Actinium Pharmaceuticals Inc. with risk reward ratio chartsDividend Strategy Summary With 10-Year Outlook - Newser
Published on: 2025-08-09 00:23:20 - Newser
Actinium: Q2 Earnings Snapshot - San Francisco Chronicle
Is Actinium Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Immediate Entry Point Prediction Strategy - Newser
Financial Contrast: Gemini Therapeutics (NASDAQ:GMTX) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
What institutional flow reveals about Actinium Pharmaceuticals Inc.Real Market Tracker with Price Action Tools - Newser
Can machine learning forecast Actinium Pharmaceuticals Inc. recoveryShort Term Profit Strategy with Entry Cues - Newser
What moving averages say about Actinium Pharmaceuticals Inc.AI Intraday Market Movement Prediction Tool - Newser
Is it time to cut losses on Actinium Pharmaceuticals Inc.Volatility Analysis and Entry Risk Mapping - Newser
How strong is Actinium Pharmaceuticals Inc. company’s balance sheetFree Buy/Sell Signal Notifications - Jammu Links News
What are the latest earnings results for Actinium Pharmaceuticals Inc.Consistent triple-digit returns - Jammu Links News
What analysts say about Actinium Pharmaceuticals Inc. stockSuperior returns - Jammu Links News
What is the dividend policy of Actinium Pharmaceuticals Inc. stockHigh-performance stocks for savvy investors - Jammu Links News
Is it the right time to buy Actinium Pharmaceuticals Inc. stockAccelerated capital growth - Jammu Links News
What institutional investors are buying Actinium Pharmaceuticals Inc. stockAchieve breakthrough gains with expert advice - Jammu Links News
How does Actinium Pharmaceuticals Inc. compare to its industry peersGet daily expert analysis on top stocks - Jammu Links News
When is Actinium Pharmaceuticals Inc. stock expected to show significant growthAchieve consistent double-digit returns - Jammu Links News
What is Actinium Pharmaceuticals Inc. company’s growth strategyExceptional growth trajectory - jammulinksnews.com
What are analysts’ price targets for Actinium Pharmaceuticals Inc. in the next 12 monthsInvest confidently with market-leading analysis - Jammu Links News
Is Actinium Pharmaceuticals Inc. a growth stock or a value stockUnprecedented market success - Jammu Links News
What makes Actinium Pharmaceuticals Inc. stock price move sharplyDaily Technical Forecast for Quick Gains - Newser
Key External Factors That Drive Actinium Pharmaceuticals Inc. Stock Price MovementsReal Time Growth Signal with Smart Setup - Newser
Actinium Pharmaceuticals shares rise 5.73% intraday after presenting positive data for ATNM-400 in prostate cancer treatment. - AInvest
Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficac - PR Newswire
Will Actinium Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsFree Risk Managed Intraday Trade Alerts - Newser
Actinium Pharmaceuticals Inc. recovery potential after sell offWatchlist Generator for Smart Money Signals - Newser
Published on: 2025-07-31 05:11:29 - metal.it
What’s next for Actinium Pharmaceuticals Inc. stock priceTrade Scanner With Buy Zone Alerts Flagged - metal.it
How Actinium Pharmaceuticals Inc. stock performs during market volatilityShort Term Alpha Signals Insight - beatles.ru
How to interpret RSI for Actinium Pharmaceuticals Inc. stockChart Based Entry Tool for ROI Traders - Newser
Actinium Pharmaceuticals Inc.’s Price Action Aligns with Quant SignalsTriple Digit Return Stock Predictions Released - beatles.ru
Can Actinium Pharmaceuticals Inc. Rally Enough to Break EvenTriple Return Setup With Risk Control Explained - metal.it
Published on: 2025-07-29 14:09:30 - metal.it
Is Actinium Pharmaceuticals Inc. showing signs of accumulationMarket Downturn Defense Strategy Analysis - Newser
Actinium Pharmaceuticals Inc Azioni (ATNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):